ESE Prizes: Deadline 31 December 2006

The deadline for the Geoffrey Harris and EJE Prizes is fast approaching. For more information visit the ESE website's "Jobs & Grants" page (link below) or see the "Jobs, Grants & Prizes" section of this email alert below.

ESE Jobs & Grants

Closing date for membership applications

All applications for Ordinary membership are formally approved by the ESE Executive Committee and by the full membership at the Annual General Meeting. The next AGM will be held in Budapest in 2007 and the closing date for applications to be approved at this AGM is 6 February 2007. Application forms are available via the link below.

Download application form here

ECE 2007 Registration & Abstracts

ECE 2007 takes place 28 April - 2 May. The on-line registration form is available on the website, link below. Early bird registration rates are available until 15 January 2007. The abstract deadline has now passed, and we are pleased to announce that we have received over 800 submissions.

Online registration

ESE AGM

The Annual General Meeting will be held at the ECE 2007 on Tuesday 1 May 2007 at 18.30.

ECE 2008

The website for the 10th European Congress of Endocrinology from 3-7 May 2008 in Berlin is now open for viewing. To join the mailing list follow the link below.

ECE 2008

EU parliament calls for breast cancer screening (Reuters, 26 October)

STRASBOURG, France (Reuters) - The European Parliament called on Wednesday for Europe-wide breast cancer screening to fight a disease that kills 88,000 women a year in the European Union. In a non-binding resolution, the Strasbourg-based assembly said the EU's 25 members were not doing enough to combat the cancer that is a leading cause of death among women aged between 35 and 59. Despite an EU guideline in 1992, only 11 members offer nationwide mammographic screening -- Belgium, the Czech Republic, Estonia, Finland, France, Hungary, Luxembourg, the Netherlands, Sweden, Spain and Britain.

Full article

Everyday Chemicals And Health - Assessing New Research Findings On Endocrine Disrupters (Medical News Today, 14 October)

Reports show that genital malformations in baby boys have been on the increase in many European countries, and that the number of people diagnosed with breast, testis and prostate cancers continues to increase. Recent data indicate that in parts of Europe, sperm quality is approaching levels that may impair fertility. At the same time, wildlife in certain areas of Europe shows signs of sexual disruption. The concern is that chemicals able to interfere with the normal functioning of hormones, so-called endocrine disrupters, may play a role in these conditions.

Full article

Breast cancer patients poorly informed re hormone therapy (Reuters, 30 Sept 06)

Older European breast cancer patients without access to the Internet are not well informed about hormone treatments that can reduce the risk of a recurrence, researchers have said. Only 22 percent of 547 cancer patients in nine European countries who took part in a survey knew about or had a say in deciding to take hormone therapy after undergoing surgery to remove their tumour.

Full Article

Request for a scientific opinion: Phthalates in Cosmetics

In February 2005 Greenpeace released An Investigation of Chemicals in Perfumes. In the investigation inter alia the presence of 10 different phthalates were examined. Phthalates were found in 35 out of 36 investigated perfumes...The Greenpeace investigation raises a general health and environmental concern about chemicals in perfumes, points out limits in the existing legislation against e.g. endocrine disruptors and states that, "traditional narrow risk assessment techniques are unlikely to provide adequate protection". For all details click on the link below.

Link

New: EDID EDCs Diet Interaction Database

The italian website "Endocrine disrupters" has been updated with a new section dedicated to a brand new database named EDID: EDCs Diet Interaction Database.

Link

WADA 2007 Prohibited List Now Published

Following its approval by WADA's Executive Committee on September 16, the 2007 List of Prohibited Substances and Methods is now available. This List will go into effect January 1, 2007. To see the 2007 List, the 2007 Monitoring Program and a summary of modifications, click on the link below.

WADA Prohibited List

Ectopic ACTH syndrome: our experience with 25 cases

Luiz Roberto Salgado, Maria Candida B Villares Fragoso, Mirta Knoepfelmacher, Marcio Carlos Machado, Sorahia Domenice, Maria Adelaide Albergaria Pereira and Berenice Biharinho de Mendonça. Ectopic adrenocorticotrophic hormone (ACTH) syndrome (EAS) is seen in between 5 and 10% of patients with ACTH-dependent hypercortisolism. Caused by excessive ACTH secretion and malignant intrathoracic tumours, its characteristics include; proximal myopathy, hypokalaemia, hyperpigmentaion and glucose intolerance. Hypokalaemia is often a distinguishing feature of EAS, being more common in this syndrome than in another similar disorder - Cushing's disease. The differentiation between EAS and Cushing's disease is difficult and requires accurate tests to make a correct diagnosis. Here, Salgado and colleagues assess the accuracy of dynamic tests and imaging techniques currently used to diagnose EAS. Their findings suggest that, of several dynamic tests, which alter levels of cortisol or corticotrophin-releasing hormone in Cushing's disease but not EAS, inferior petrosal sinus sampling (IPSS) using desmopressin is the most accurate and considered the 'gold standard'. Of the imaging techniques assessed, CT was considered more accurate at locating tumours than MRI, although both were effective. Positron emission tomography with fluorodeoxyglucose and scintigraphy with somatostatin analogue were also found to be relatively effective in detecting the location of occult tumours missed by CT and MRI. In conclusion, IPSS, together with less invasive dynamic tests is effective correctly diagnosing EAS in most cases, and imaging can locate the tumours at the source of the hormonal imbalance. However, many tumours still cannot be located using these existing techniques. EJE 155-5 735-743

NIH Grants

See all grants & finding opportunities at http://grants1.nih.gov/grants/index.cfm

RD Info (funding database)

For full details of funding displayed on the RD Info website, follow the link below.

RD Info

Geoffrey Harris Prize

Closing date for applications: 31 December 2006. The Geoffrey Harris prize will be presented at the 9th European Congress of Endocrinology which takes place from 28 April - 2 May 2007 in Budapest, Hungary. This important prize, generously sponsored by Ipsen, worth 15,000 Euros is designed for established researchers in the field of neuroendocrinology and is the first of its kind in Europe. For further information please check the website www.euro-endo.org or contact the ESE Secretary, Professor Philippe Bouchard, by email philippe.bouchard@sat.ap-hop-paris.fr.

European Journal of Endocrinology Prize

Closing date for applications: 31 December 2006. The European Journal of Endocrinology Prize is awarded during the European Congress of Endocrinology to a candidate who has significantly contributed to the advancement of knowledge in the field of endocrinology through publication. The prize consists of a certificate and Euro 7,250 plus travelling expenses. Nominations should be submitted to the Chief Editor of the European Journal of Endocrinology, Professor Paolo Beck-Peccoz. For more detailed information please check the websites below.

ESE Website

EJE Website

Endocrinologist position, Binghamton, New York

Endocrinology position at (Binghamton, N.Y.). Progressive multispecialty group with over 125 physicians in over 20 medical/surgical specialties is seeking a BC/BE Endocrinologist for an established 100% endocrine practice. ADA recognized diabetes program with four CDEs and a large primary care base to support the specialists. Teaching opportunities are available with F.P and I.M. residents as well as 3rd and 4th year medical students. Affiliated with community's most comprehensive hospital and health care system, a community-owned, not-for-profit organization operating two major acute care hospitals. Contact the Director of Physician Services, email: mary_gibson@uhs.org; phone (800) 295-1788; fax (607) 763-6717.

European Foundation for the Study of Diabetes (EFSD) CLINICAL RESEARCH GRANT in Type 2 Diabetes

Request for Applications. The European Association for the Study of Diabetes (EASD) was founded in Montecatini, Italy, in 1965. In 1999, the Association created the European Foundation for the Study of Diabetes (EFSD). The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application. EFSD have recently announced that up to Euro 1.2 million has been made available for up to 4 grants over 3 years, for research in the framework of the programme and performed in Europe and its associated countries. Applications should be submitted by 1 December 2006. For full details visit the EASD website, go to the News Section and follow the link for All News. The link below takes you to the EASD Homepage.

EASD Website

If you have any feedback on the content of the alert, email: jo.thurston@endocrinology.org

Please feel free to pass this email alert on to anyone you think may be interested.